1200 related articles for article (PubMed ID: 28852310)
1. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ
World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-143 and -205 expression in neosquamous esophageal epithelium following Argon plasma ablation of Barrett's esophagus.
Dijckmeester WA; Wijnhoven BP; Watson DI; Leong MP; Michael MZ; Mayne GC; Bright T; Astill D; Hussey DJ
J Gastrointest Surg; 2009 May; 13(5):846-53. PubMed ID: 19190970
[TBL] [Abstract][Full Text] [Related]
3. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma.
Wu X; Ajani JA; Gu J; Chang DW; Tan W; Hildebrandt MA; Huang M; Wang KK; Hawk E
Cancer Prev Res (Phila); 2013 Mar; 6(3):196-205. PubMed ID: 23466817
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1.
Streppel MM; Pai S; Campbell NR; Hu C; Yabuuchi S; Canto MI; Wang JS; Montgomery EA; Maitra A
Clin Cancer Res; 2013 Aug; 19(15):4067-78. PubMed ID: 23757351
[TBL] [Abstract][Full Text] [Related]
6. Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy.
Odze RD; Lauwers GY
Endoscopy; 2008 Dec; 40(12):1008-15. PubMed ID: 19065484
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium.
Drahos J; Schwameis K; Orzolek LD; Hao H; Birner P; Taylor PR; Pfeiffer RM; Schoppmann SF; Cook MB
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):429-37. PubMed ID: 26604271
[TBL] [Abstract][Full Text] [Related]
8. Pseudo-buried Barrett's post radiofrequency ablation for Barrett's esophagus, with or without prior endoscopic resection.
Pouw RE; Visser M; Odze RD; Sondermeijer CM; ten Kate FJ; Weusten BL; Bergman JJ
Endoscopy; 2014 Feb; 46(2):105-9. PubMed ID: 24285123
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma.
Wijnhoven BP; Hussey DJ; Watson DI; Tsykin A; Smith CM; Michael MZ;
Br J Surg; 2010 Jun; 97(6):853-61. PubMed ID: 20301167
[TBL] [Abstract][Full Text] [Related]
10. miR-24-3p regulates CDX2 during intestinalization of cardiac-type epithelium in a human model of Barrett's esophagus.
Gil-Gómez G; Fassan M; Nonell L; Garrido M; Climent M; Anglada R; Iglesias M; Guzzardo V; Borga C; Grande L; de Bolós C; Pera M
Dis Esophagus; 2021 Jul; 34(7):. PubMed ID: 33558874
[TBL] [Abstract][Full Text] [Related]
11. miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus.
Smith CM; Watson DI; Leong MP; Mayne GC; Michael MZ; Wijnhoven BP; Hussey DJ
World J Gastroenterol; 2011 Feb; 17(8):1036-44. PubMed ID: 21448356
[TBL] [Abstract][Full Text] [Related]
12. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J
Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377
[TBL] [Abstract][Full Text] [Related]
13. Molecular biomarkers and ablative therapies for Barrett's esophagus.
Chisholm JA; Mayne GC; Hussey DJ; Watson DI
Expert Rev Gastroenterol Hepatol; 2012 Sep; 6(5):567-81. PubMed ID: 23061708
[TBL] [Abstract][Full Text] [Related]
14. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218
[TBL] [Abstract][Full Text] [Related]
15. Clonal selection and persistence in dysplastic Barrett's esophagus and intramucosal cancers after failed radiofrequency ablation.
Zeki SS; Haidry R; Graham TA; Rodriguez-Justo M; Novelli M; Hoare J; Dunn J; Wright NA; Lovat LB; McDonald SA
Am J Gastroenterol; 2013 Oct; 108(10):1584-92. PubMed ID: 23939625
[TBL] [Abstract][Full Text] [Related]
16. Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?
Rajendra S; Sharma P
Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 31304554
[TBL] [Abstract][Full Text] [Related]
17. Stepwise radical endoscopic resection of the complete Barrett's esophagus with early neoplasia successfully eradicates pre-existing genetic abnormalities.
Peters FP; Krishnadath KK; Rygiel AM; Curvers WL; Rosmolen WD; Fockens P; Ten Kate FJ; van Baal JW; Bergman JJ
Am J Gastroenterol; 2007 Sep; 102(9):1853-61. PubMed ID: 17509033
[TBL] [Abstract][Full Text] [Related]
18. [Radio frequency ablation of Barrett's esophagus--can the risk of esophageal adenocarcinoma be reduced?].
Salminen P; Räsänen J; Ristimäki A; Saarnio J; Heikkinen M; Laine S; Koivisto T; Färkkilä M
Duodecim; 2014; 130(6):557-64. PubMed ID: 24724454
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 expression in esophageal epithelium before and after photodynamic therapy for Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
Yachimski P; Mino-Kenudson M; Sherwood ME; Puricelli WP; Nishioka NS; Lauwers GY
Virchows Arch; 2011 Dec; 459(6):581-6. PubMed ID: 22081106
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett's carcinogenesis.
Fassan M; Realdon S; Cascione L; Hahne JC; Munari G; Guzzardo V; Arcidiacono D; Lampis A; Brignola S; Dal Santo L; Agostini M; Bracon C; Maddalo G; Scarpa M; Farinati F; Zaninotto G; Valeri N; Rugge M
Pathol Res Pract; 2020 May; 216(5):152907. PubMed ID: 32131978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
